Optogenetic modeling of primary and secondary CNS proteinopathies in Drosophila
果蝇原发性和继发性中枢神经系统蛋白病的光遗传学模型
基本信息
- 批准号:8771014
- 负责人:
- 金额:$ 22.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-01 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAlzheimer&aposs DiseaseAmino Acid MotifsAmyloid beta-ProteinAnimal ModelAnimalsBindingBiochemicalBypassCell NucleusCellsChemicalsComplexCoupledCyanobacteriumCytoplasmCytosolDNA Binding DomainDataDevelopmentDevelopmental ProcessDevicesDiseaseDrosophila genusDrosophila melanogasterElementsEngineeringEnzymesEpitopesEventExperimental ModelsFigs - dietaryGene ExpressionGenesGoalsGrowth and Development functionHeadHeme GroupHumanImpaired cognitionLightLightingLinkModelingMolecular ConformationNerve DegenerationNeurodegenerative DisordersNuclearNuclear Localization SignalPathologyPhotoreceptorsPhysiologic pulsePhytochromePlantsProteinsPublic HealthReporter GenesResearchResolutionSensorySignal TransductionSystemTechnologyTimeTransactivationTransgenic AnimalsTransgenic OrganismsViral ProteinsWorkbasebeta-site APP cleaving enzyme 1cell typechromophoreconformerdesigndrug discoveryflexibilityflygene discoveryin vivoinnovationnervous system disorderneurotoxicnoveloptogeneticsphotoactivationphyB phytochromeplant growth/developmentprotein TDP-43protein expressionprototypepublic health relevanceresearch studyresponsespatiotemporaltau Proteinstooltranscription factortransgene expression
项目摘要
DESCRIPTION (provided by applicant): Recent evidence indicates that abnormal accumulation of multiple disease-associated proteins co-exists in several neurodegenerative disorders. For instance, Abeta, tau and TDP-43 pathology can be found in some Alzheimer's disease cases, while tau and TDP-43 abnormalities are evident in ALS with cognitive impairment. However, very little is known about how tau, Abeta and TDP-43 interact with each other in different cell types and in different disease context. Unfortunately, these questions are difficult to address because these proteins induce developmental abnormalities or early lethality when co-expressed in transgenic animals. Thus, a new strategy for the spatio-temporal control of multiple genes will be essential to address this challenge. To that end, we have developed a new genetically encoded light-switchable system based on the fast, reversible photoactivation of Phytochrome B (PhyB) from plants. Phytochromes are sensory photoreceptors that regulate plant growth in response to light signals and require a covalently linked chromophore for proper function. In response to red light, the phytochrome-chromophore complex changes its conformation and translocates to the nucleus to trigger signal transduction. In the dark or under far-red light, its conformation returns to the inactive state and PhyB accumulates in the cytosol. Thus, we will exploit this light-dependent, conformer-specific interaction in plants to develop a new light switchable gene expression system in transgenic animals. This system, which we have called PhotoGal4, will encode for all the elements required for the formation of the phytochrome-chromophore complexes in animal cells along with protein motifs required for transcriptional activity. We will use the fruit fly Drosophila melanogaster as our initial animal model to implement this new optogenetic system. In Specific Aim 1, we will characterize the light- dependent activation and reversibility of PhotoGal4 in adult flies. In Specific Aim 2, we wil use PhotoGal4 to generate optogenetic models of primary and secondary CNS proteinopathies involving Abeta, tau and TDP-43. Our central hypothesis is that PhotoGal4 will bypass lethality issues by controlling gene expression in response to light quantity, duration and direction. This proposal is significant, innovative and potentially transformative because a successful implementation of PhotoGal4 will provide a tool for directing expression of any gene with unprecedented precision. In addition, it will provide a unique opportunity to define the sequence of events that orchestrate concomitant pathology associated with Abeta, Tau and TDP43 interactions. The elucidation of how these three proteins interact in vivo will be a significant stp forward to define the mechanisms underlying some of the most important primary and secondary CNS proteinopathies.
描述(由申请人提供):最近的证据表明,多种疾病相关蛋白的异常积累共存于多种神经退行性疾病中。例如,Abeta,tau和TDP-43病理可以在一些阿尔茨海默病病例中发现,而tau和TDP-43异常在具有认知障碍的ALS中是明显的。然而,人们对tau、Abeta和TDP-43在不同细胞类型和不同疾病背景下如何相互作用知之甚少。不幸的是,这些问题是难以解决的,因为这些蛋白质诱导发育异常或早期致死时,在转基因动物共表达。因此,一个新的战略,多个基因的时空控制将是必不可少的,以应对这一挑战。为此,我们开发了一种新的基因编码的光开关系统的基础上快速,可逆的光敏色素B(PhyB)从植物的光活化。光敏色素是一种感受性光感受器,它响应光信号调节植物生长,并且需要共价连接的发色团才能发挥适当的功能。响应于红光,光敏色素-发色团复合物改变其构象并移位到细胞核以触发信号转导。在黑暗或远红光下,其构象恢复到非活性状态,PhyB在胞质溶胶中积累。因此,我们将利用植物中这种光依赖的、适形基因特异性的相互作用,在转基因动物中开发一种新的光开关基因表达系统。这个系统,我们称之为PhotoGal 4,将编码动物细胞中光敏色素-发色团复合物形成所需的所有元件,沿着转录活性所需的蛋白基序。我们将使用果蝇Drosophila melanogaster作为我们的初始动物模型来实现这种新的光遗传学系统。在具体目标1中,我们将表征成年果蝇中PhotoGal 4的光依赖性激活和可逆性。在具体目标2中,我们将使用PhotoGal 4来产生涉及Abeta、tau和TDP-43的原发性和继发性CNS蛋白病的光遗传学模型。我们的中心假设是,PhotoGal 4将通过控制基因表达来响应光量,持续时间和方向,从而绕过致死问题。这一提议意义重大,具有创新性和潜在的变革性,因为PhotoGal 4的成功实施将提供一种工具,以前所未有的精度指导任何基因的表达。此外,它将提供一个独特的机会来定义事件的顺序,这些事件协调与Abeta,Tau和TDP 43相互作用相关的伴随病理学。阐明这三种蛋白在体内如何相互作用将是一个重要的stp前进,以确定一些最重要的原发性和继发性CNS蛋白病的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Diego E Rincon-Limas其他文献
Diego E Rincon-Limas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Diego E Rincon-Limas', 18)}}的其他基金
Harnessing new targets and mechanisms mediating AD pathogenesis
利用介导 AD 发病机制的新靶点和机制
- 批准号:
10590789 - 财政年份:2022
- 资助金额:
$ 22.5万 - 项目类别:
Functional assessment of 1,500 human genes against coexistent Abeta and tau pathology in vivo
针对体内共存的 Abeta 和 tau 病理学对 1,500 个人类基因进行功能评估
- 批准号:
10224098 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别:
Functional assessment of 1,500 human genes against coexistent Abeta and tau pathology in vivo
针对体内共存的 Abeta 和 tau 病理学对 1,500 个人类基因进行功能评估
- 批准号:
10053894 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别:
Deconstructing and challenging TDP-43 proteinopathies: from FTLD/ALS to Alzheimer's disease
解构和挑战 TDP-43 蛋白病:从 FTLD/ALS 到阿尔茨海默病
- 批准号:
10408106 - 财政年份:2018
- 资助金额:
$ 22.5万 - 项目类别:
Deconstructing and challenging TDP-43 proteinopathies: from FTLD/ALS to Alzheimer's disease
解构和挑战 TDP-43 蛋白病:从 FTLD/ALS 到阿尔茨海默病
- 批准号:
9918238 - 财政年份:2018
- 资助金额:
$ 22.5万 - 项目类别:
Deconstructing and challenging TDP-43 proteinopathies: from FTLD/ALS to Alzheimer's disease
解构和挑战 TDP-43 蛋白病:从 FTLD/ALS 到阿尔茨海默病
- 批准号:
9759749 - 财政年份:2018
- 资助金额:
$ 22.5万 - 项目类别:
Deconstructing and challenging TDP-43 proteinopathies: from FTLD/ALS to Alzheimer's disease
解构和挑战 TDP-43 蛋白病:从 FTLD/ALS 到阿尔茨海默病
- 批准号:
10180834 - 财政年份:2018
- 资助金额:
$ 22.5万 - 项目类别:
Uncovering targets that block pathological interactions between Abeta and tau
发现阻断 Abeta 和 tau 之间病理性相互作用的靶点
- 批准号:
9373909 - 财政年份:2017
- 资助金额:
$ 22.5万 - 项目类别:
Targeting nuclear transport dysfunction in TDP-43 proteinopathies
靶向 TDP-43 蛋白病中的核转运功能障碍
- 批准号:
9246585 - 财政年份:2016
- 资助金额:
$ 22.5万 - 项目类别:
Targeting nuclear transport dysfunction in TDP-43 proteinopathies
靶向 TDP-43 蛋白病中的核转运功能障碍
- 批准号:
9092579 - 财政年份:2016
- 资助金额:
$ 22.5万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 22.5万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)